Founded in 1998 by Leonard A. Lauder and Ronald S. Lauder, the Alzheimer’s Drug Discovery Foundation (ADDF) was one of the first charities to adopt the venture philanthropy model. Our mission is to rapidly accelerate the discovery of drugs to prevent and treat Alzheimer’s disease and related dementias. We are the only charity focused solely on supporting new drugs for Alzheimer’s. 

Research

Alzheimer's Drug Discovery Foundation

Mark Roithmayr

Richard C. Mohs

Sharon T. Sager

The Board Members at the Alzheimer's Drug Discovery Foundation provide strategic oversight and governance, guiding the organization's mission to accelerate drug discovery for Alzheimer's disease and related dementias. They leverage their diverse expertise to advise on funding initiatives, ensure financial accountability, and foster partnerships within the biomedical community, all aimed at expediting breakthroughs in treatment and prevention.

Board Members

About

Team members